Active	Status	Sponsor type	Region	Phase	Filter
27 Active 64 Inactive 91 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tack, Jan
MOVE-IT, NCT05621811 / 2021-002254-86: Different Doses of Naronapride vs. Placebo in Gastroparesis	Recruiting	2	320	Europe, US	Naronapride, Placebo	Dr. Falk Pharma GmbH, Dr. Falk Pharma GmbH	Gastroparesis	01/25	04/25
PASIPHY, NCT05928390: Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia	Recruiting	2	72	Europe, US	Pasireotide Diaspartate, Pasireotide	RECORDATI GROUP	Post-Bariatric Hypoglycemia	04/25	04/26
OCARINA, NCT05740631 / 2020-004180-13: The Effect of Obeticholic Acid in Healthy Volunteers	Recruiting	N/A	12	Europe	Ocaliva, obeticholic acid, Placebo, Placebo Oral Tablet (Starch)	Universitaire Ziekenhuizen KU Leuven, Intercept Pharmaceuticals	Healthy	07/23	07/23
NCT05780749: A 14-week Pilot Prospective Clinical Trial With BiOkuris Product in Patients With Irritable Bowel Syndrome	Recruiting	N/A	130	Europe	DDI-IBS-001, DDDI-IBS-001 placebo	Biokuris s.a.	Irritable Bowel Syndrome	12/24	12/24